Gamma-sarcoglycanopathy: Clinical Trials

1 trial for Gamma-sarcoglycanopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Gamma-sarcoglycanopathy: new trials by email Literature Review of Gamma-sarcoglycanopathy trials Research Report on Gamma-sarcoglycanopathy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C
AAV1-gamma-sarcoglycan vector injection - Limb Girdle Muscular Dystrophy Type 2C, Gamma-sarcoglycanopathy
Phase 1CompletedGenethon92006-11-012011-04-29

Narrower conditions

Limb-girdle muscular dystrophy, type 2C (1)  ·  Neuromuscular Diseases (1)  ·  Rare Diseases (1)

Broader conditions

Disease Attributes (1)  ·  Nervous System Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Sponsors

Genethon (1)

Countries

France (1)

Top investigators

Serge Herson, Prof (1)